Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05537441 · ClinicalTrials.gov registry record · NA
Precision Vaccine Promotion in Underserved Populations
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 228,831
- Enrollment target
NCT05537441 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 228,831 participants.
The verdict
NCT05537441, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 228,831 participants
- Enrollment target
Study Summary
Previous studies have shown that low-cost, behavioral nudges through texting can increase influenza vaccination uptake compared to usual care. However, there are limited studies that evaluate the effect of decreasing barriers to scheduling, especially within safety net populations. The setting for this study, DHS, is the second largest public delivery system in the country and serves approximately half a million diverse patients that are eligible for vaccinations annually. This pilot study (one arm in a larger randomized controlled trial) will examine the effect of text messages highlighting MediCal health plan transportation resources (vs standard text messaging) on influenza vaccination rates in adults during the 2022-2023 flu season.
Interventions
- BEHAVIORAL Text messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228,831 participants |
| Start Date | 2022-09-22 |
| Est. Completion | 2023-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05537441
The ClinicalTrials.gov registry entry for NCT05537441 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 228,831 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Text messaging is the first listed.
NCT05537441 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05537441 about?
NCT05537441 is a clinical study titled "Precision Vaccine Promotion in Underserved Populations". Previous studies have shown that low-cost, behavioral nudges through texting can increase influenza vaccination uptake compared to usual care. However, there are limited studies that evaluate the effect of decreasing barriers to scheduling, especially within safety net populations. The setting for t...
What is the current status of trial NCT05537441?
This trial is currently completed. It is a NA study. The enrollment target is 228,831 participants. The study started on 2022-09-22. Estimated completion is 2023-06-01.
What interventions are being tested in trial NCT05537441?
The interventions under investigation include: Text messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT05537441?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.